ONEMEDNET CORPORATION Operating Lease Cost
ONEMEDNET CORPORATION (ONMD) reported Operating Lease Cost of $575 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-04-09.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseCost · last filed 2024-04-09
- ONEMEDNET CORPORATION operating lease, cost for the quarter ending 2023-12-31 was $0.00.
- ONEMEDNET CORPORATION operating lease, cost for fiscal 2023 was $575.00.
| Period end | Operating Lease, Cost 3 month | Operating Lease, Cost 9 month | Operating Lease, Cost 12 month |
|---|---|---|---|
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-04-09 | $575.00 10-K · filed 2024-04-09 | |
| 2023-09-30 | $575.00 10-Q · filed 2023-11-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| bioAffinity Technologies, Inc. (BIAF) | United States | $0.063B | |
| iSpecimen Inc. (ISPC) | United States | $0.003B | |
| FOXO TECHNOLOGIES INC. (FOXO) | United States | $0.000B | -277.71 |
| MAXCYTE, INC. (MXCT) | United States | $0.124B | -3.68 |
| NRC HEALTH (NRC) | United States | $0.450B | 42.50 |
| OmniAb, Inc. (OABI) | United States | $0.698B | -8.05 |
| Absci Corp (ABSI) | United States | $1.775B | -14.92 |
| CHARLES RIVER LABORATORIES INTERNATIONAL, INC. (CRL) | United States | $14.060B | -43.97 |
| Medpace Holdings, Inc. (MEDP) | United States | $17.316B | 30.09 |
| INCYTE CORP (INCY) | United States | $24.855B | 13.14 |